Petznick Allison M, Shubrook Jay H
Diabetes and Endocrine Center, Ohio University College of Osteopathic Medicine, Athens, OH 45701, USA.
Osteopath Med Prim Care. 2010 Aug 11;4:5. doi: 10.1186/1750-4732-4-5.
In 2007, over 23 million people had diabetes in the United States and death from cardiovascular disease is estimated to occur in 80% of those Americans. Risk factor reduction is the most important therapy for primary and secondary prevention of macrovascular disease in patients with and without diabetes mellitus. Despite this, presentation and response to therapy is often different for patients with diabetes compared to their non-diabetic counterparts. This paper will review the current targets for therapy of cardiovascular disease, peripheral vascular disease, and cerebrovascular disease in patients with diabetes.
2007年，美国有超过2300万人患有糖尿病，估计80%的美国糖尿病患者死于心血管疾病。降低危险因素是糖尿病患者和非糖尿病患者大血管疾病一级和二级预防的最重要治疗方法。尽管如此，与非糖尿病患者相比，糖尿病患者的临床表现和对治疗的反应往往有所不同。本文将综述糖尿病患者心血管疾病、外周血管疾病和脑血管疾病的当前治疗目标。
